| Zacks Company Profile for ERBA Diagnostics, Inc. (ERBA : OTC) |
|
|
| |
| • Company Description |
| ERBA Diagnostics, Inc. develops, manufactures and markets diagnostic test kits, or assays, and automated systems primarily for autoimmune and infectious diseases. The main subsidiaries of the company include: Diamedix Corporation, Delta Biologicals S.r.l. and ImmunoVision, Inc. ERBA Diagnostics, Inc., formerly known as IVAX Diagnostics, Inc., is headquartered in Miami, Florida.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $ |
Daily Weekly Monthly
 |
| 20 Day Moving Average: shares |
| Shares Outstanding: (millions) |
| Market Capitalization: $ (millions) |
| Beta: |
| 52 Week High: $0.31 |
| 52 Week Low: $0.01 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
% |
% |
| 12 Week |
% |
% |
| Year To Date |
% |
% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Suresh Vazirani - Executive Chairman of the Board of Directors
Mohan Gopalkrishnan - Chief Executive Officer
Kishore Dudani - Director
Philippe Gadal, Pharm.D. - Director
Gerald E. Gallwas - Director
|
|
Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 29490B101
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $ (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: % |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |
